Presbyopia is a natural part of the aging process of your eyes.
This condition causes blurred vision while trying to read or work on a computer, tablet, or smartphone. It can occur as early as your 40s.
Up until now, options for patients in the U.S. with near vision loss have been limited to reading glasses, bifocals or surgical procedures that compromise patients' distance vision and offer no guarantee of lasting success.
What is the breakthrough treatment that can help cure presbyopia?
Dr. Tom Tooma joins Dr. Mike to discuss presbyopia and the newest treatment options available.
Breakthrough Treatment for Presbyopia
Featured Speaker:
Dr. Tom Tooma, MD, is the founder at NVISION Eye Centers. A preeminent leader, Dr. Tooma was the first doctor in California to perform LASIK surgery, the first to perform Custom Wavefront Guided LASIK and the first to use the FemtoSecond Laser (IntraLase FS30 – All Laser LASIK), a safer and more precise method than a traditional blade to increase a patient's chances of achieving 20/20, or better, vision.
Dr. Tooma received his M.D. from Loma Linda University School of Medicine, where he also completed his internship in internal medicine and residency in ophthalmology. He completed his fellowship in Corneal Surgery and External Disease at the Emory University Department of Ophthalmology in Atlanta, Georgia, and has been a board-certified ophthalmologist for more than 25 years.
Dr. Tom Tooma, MD, is the founder at NVISION Eye Centers. A preeminent leader, Dr. Tooma was the first doctor in California to perform LASIK surgery, the first to perform Custom Wavefront Guided LASIK and the first to use the FemtoSecond Laser (IntraLase FS30 – All Laser LASIK), a safer and more precise method than a traditional blade to increase a patient's chances of achieving 20/20, or better, vision.Dr. Tooma received his M.D. from Loma Linda University School of Medicine, where he also completed his internship in internal medicine and residency in ophthalmology. He completed his fellowship in Corneal Surgery and External Disease at the Emory University Department of Ophthalmology in Atlanta, Georgia, and has been a board-certified ophthalmologist for more than 25 years.